CardioComm Solutions Inc. Cash Flow Conversion Efficiency

Latest as of September 2025: 0.215x

CardioComm Solutions Inc. cash flow conversion efficiency. Based on the latest financial reports, CardioComm Solutions Inc. (EKG) has a cash flow conversion efficiency ratio of 0.215x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-121.85K ≈ $-88.15K USD) by net assets (CA$-567.74K ≈ $-410.69K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of CardioComm Solutions Inc. (2013–2024)

Cash flow conversion efficiency of CardioComm Solutions Inc. from 2013 to 2024. This chart illustrates how CardioComm Solutions Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for CardioComm Solutions Inc. for real-time trading data and today's change.

CardioComm Solutions Inc. Cash Flow Conversion Ratio Explained

CardioComm Solutions Inc. cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

CardioComm Solutions Inc. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of CardioComm Solutions Inc. ranked by their cash flow conversion efficiency. Also see how much is CardioComm Solutions Inc. worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Protagenic Therapeutics NASDAQ:PTIX	0.087x
Cho Thavee Public Company Limited BK:CHO	-0.006x
Reneuco Berhad KLSE:7130	0.013x
Goldex Resources Corp V:GDX	0.000x
ETRUSCUS RESOURCES CORP. F:ERR	-0.014x
Thai Polycons Public Company Limited BK:TPOLY	0.129x
Niraj Ispat Industries Limited NSE:NIRAJISPAT	0.006x
Ausmon Resources Ltd AU:AOA	-0.232x

Annual Cash Flow Conversion Efficiency for CardioComm Solutions Inc. (2013–2024)

The table below shows the annual cash flow conversion efficiency of CardioComm Solutions Inc. from 2013 to 2024. Review EKG cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CA$-276.58K ≈ $-200.07K	CA$-110.66K ≈ $-80.05K	0.400x	+273.45%
2023-12-31	CA$-504.65K ≈ $-365.06K	CA$-54.07K ≈ $-39.11K	0.107x	+180.05%
2022-12-31	CA$-407.32K ≈ $-294.65K	CA$54.52K ≈ $39.44K	-0.134x	-146.91%
2021-12-31	CA$-423.38K ≈ $-306.26K	CA$-120.80K ≈ $-87.38K	0.285x	+585.41%
2020-12-31	CA$-670.32K ≈ $-484.90K	CA$39.40K ≈ $28.50K	-0.059x	-185.08%
2019-12-31	CA$-895.81K ≈ $-648.01K	CA$-61.89K ≈ $-44.77K	0.069x	-97.55%
2018-12-31	CA$-68.41K ≈ $-49.49K	CA$-192.53K ≈ $-139.27K	2.814x	+572.08%
2017-12-31	CA$489.32K ≈ $353.96K	CA$-291.70K ≈ $-211.01K	-0.596x	-102.26%
2016-12-31	CA$-7.74K ≈ $-5.60K	CA$-204.16K ≈ $-147.68K	26.374x	+6060.44%
2015-12-31	CA$-687.89K ≈ $-497.61K	CA$-294.50K ≈ $-213.03K	0.428x	-44.88%
2014-12-31	CA$-595.83K ≈ $-431.02K	CA$-462.75K ≈ $-334.75K	0.777x	-72.03%
2013-12-31	CA$-339.45K ≈ $-245.56K	CA$-942.44K ≈ $-681.75K	2.776x	--

About CardioComm Solutions Inc.

V:EKG Canada Health Information Services

Market Cap

$1.43 Million

CA$1.98 Million CAD

Market Cap Rank

#30386 Global

#1523 in Canada

Share Price

CA$0.01

Change (1 day)

+0.00%

52-Week Range

CA$0.01 - CA$0.02

All Time High

CA$0.12